| Patents for A61P 1 - Drugs for disorders of the alimentary tract or the digestive system (125,798) |
|---|
| 01/13/2000 | WO2000001676A1 Potassium channel blocking agents |
| 01/13/2000 | WO2000001395A1 Hypo-osmotic saline solutions, method for preparing same and medicines based on said solutions |
| 01/13/2000 | WO2000001372A2 Chewable oral unit dosage |
| 01/13/2000 | WO1999058540A3 1-galactose derivatives |
| 01/13/2000 | DE19830431A1 Sulfonylamino-carbonsäure-N-arylamide als Guanylatcyclase-Aktivatoren Sulfonylamino-carboxylic acid N-arylamides as guanylate cyclase activators |
| 01/13/2000 | CA2336315A1 Benzothiepines having activity as inhibitors of ileal bile acid transport and taurocholate uptake |
| 01/13/2000 | CA2335920A1 Hypo-osmotic saline solutions, method for preparing same and medicines based on said solutions |
| 01/13/2000 | CA2332699A1 Antisense oligonucleotides targeted to il-15 |
| 01/13/2000 | CA2301510A1 3-alkylpyrrolo[3,2-c]quinoline derivatives |
| 01/12/2000 | EP0970219A1 A porin gene from campylobacter jejuni, related products and uses thereof |
| 01/12/2000 | EP0970218A1 Variants of vascular endothelial cell growth factor having altered pharmacological properties, and related aspects thereof |
| 01/12/2000 | EP0970212A1 Secreted salivary zsig32 polypeptides |
| 01/12/2000 | EP0970112A2 Novel human cytokine/steroid receptor protein |
| 01/12/2000 | EP0970082A2 Biazacyclic crf antagonists |
| 01/12/2000 | EP0970060A1 Lta 4 hydrolase inhibitors |
| 01/12/2000 | EP0970046A1 N-hydroxy-2-(alkyl, aryl, or heteroaryl sulfanyl, sulfinyl or sulfonyl)-3-substituted alkyl, aryl or heteroarylamides as matrix metalloproteinase inhibitors |
| 01/12/2000 | EP0969828A1 Butyrate prodrugs derived from lactic acid |
| 01/12/2000 | EP0969827A1 Mixture of primary fatty acids obtained from sugar cane wax |
| 01/12/2000 | EP0969819A2 New crystalline form of omeprazole |
| 01/12/2000 | EP0969813A2 Topical pharmaceutical composition comprising a cholinergic agent or a calcium channel blocker |
| 01/12/2000 | EP0862566B1 1-(1,2-disubstituted piperidinyl)-4-substituted piperazine derivatives |
| 01/12/2000 | EP0640081B1 Substituted phenylcarbamates and phenylureas, their preparation and their use as 5-ht4 antagonists |
| 01/12/2000 | EP0639079B1 Methods for treating interleukin-1 and tumor necrosis factor mediated diseases |
| 01/12/2000 | CN1241183A Novel compound form |
| 01/12/2000 | CN1241178A Novel compounds with analgesic effect |
| 01/12/2000 | CN1241177A Substed. 4-biphenyl-4-hydroxybutyric acid derivs. as matrix metalloprotease inhibitors |
| 01/12/2000 | CN1240662A Chinese medicine preparation for treating infantile diarrhea |
| 01/12/2000 | CN1240652A Medical extract for treating constipation |
| 01/12/2000 | CN1048245C 5-pyrrolyl-2-pyridylmethylsulfinyl benzimidazole derivs., their preparing process and anti-ulcer composition contg. same |
| 01/11/2000 | US6013792 Matrix metalloprotease inhibitors |
| 01/11/2000 | US6013670 Administering c1-c6 alkanoyl carnitine or salt to treat chronic inflammatory bowel disease |
| 01/11/2000 | US6013656 2-(arylalkenyl) azacycloalkane derivatives as ligands for sigma receptors |
| 01/11/2000 | US6013640 Antiischemic agents |
| 01/11/2000 | US6013635 Treatment of C. difficile toxin B associated conditions |
| 01/11/2000 | US6013497 Polynucleotide sequence that codes a polypeptide; bactericides |
| 01/11/2000 | US6013476 DNA encoding tumor necrosis related receptor TR7 |
| 01/11/2000 | US6013463 Diagnostic test kit for detecting campylobacter infection; for diagnosis of peptic ulcer disease or gastrointestinal cancer |
| 01/11/2000 | US6013455 Polynucleotides which identify and encode protein kinase homologs, amino acid sequences encoding pkh; methods of pkh production with expression vectors; hybridizes under given conditions |
| 01/11/2000 | US6013454 Kinesin-like motor protein |
| 01/11/2000 | US6013448 Pancreas-derived serpin |
| 01/11/2000 | US6013281 Method of making a pharmaceutical dosage form comprising a proton pump inhibitor |
| 01/11/2000 | US6013273 For the treatment of endotoxic shock, enterally administering to a human or other mammal in need of such a treatment an effective amount of choline for reducing endotoxin-induced injucry or mortality |
| 01/11/2000 | US6012375 Aircraft infrared guided defense missile system |
| 01/11/2000 | CA2247114C Liquid oral compositions comprising a calcium compound and an acidulant |
| 01/06/2000 | WO2000000594A2 Human transferases |
| 01/06/2000 | WO2000000587A1 Methods of expanding and selecting disease associated t-cells |
| 01/06/2000 | WO2000000510A2 Growth factor modulators |
| 01/06/2000 | WO2000000477A1 Non-peptidyl inhibitors of vla-4 dependent cell binding useful in treating inflammatory, autoimmune, and respiratory diseases |
| 01/06/2000 | WO2000000223A2 ANTIVIRAL AND ANTIRETROVIRAL RADIOIMMUNOMEDICAMENTS BASED ON α-EMITTERS AND β-EMITTERS |
| 01/06/2000 | WO2000000200A1 A PHARMACEUTICAL COMBINATION COMPRISING A COX-2 INHIBITOR AND A iNOS INHIBITOR |
| 01/06/2000 | WO1999058133A3 Anti-diarrheal and method for using the same |
| 01/06/2000 | WO1999057270A3 Human receptor molecules |
| 01/06/2000 | WO1999056723A3 Hemoglobine-haptoglobin complexes for targeted drug delivery |
| 01/06/2000 | WO1999017759A3 Methods of modulating serine/threonine protein kinase function with 5-azaquinoxaline-based compounds |
| 01/06/2000 | CA2336625A1 Non-peptidyl inhibitors of vla-4 dependent cell binding useful in treating inflammatory, autoimmune, and respiratory diseases |
| 01/06/2000 | CA2335516A1 Methods of expanding and selecting disease associated t-cells |
| 01/06/2000 | CA2334515A1 A pharmaceutical combination comprising a cox-2 inhibitor and a inos inhibitor |
| 01/06/2000 | CA2330565A1 Growth factor modulators |
| 01/06/2000 | CA2330525A1 Human transferases |
| 01/05/2000 | EP0969005A1 Azabicyclic inhibitors of serotonin reuptake |
| 01/05/2000 | EP0968720A2 Gastric emptying-promoting composition |
| 01/05/2000 | EP0968719A2 Enzyme composition capable of forming an oligosaccharide in vivo |
| 01/05/2000 | EP0968718A1 Remedies for ulcerative colitis |
| 01/05/2000 | EP0968700A1 Material intended to remineralise organomineral tissues |
| 01/05/2000 | EP0968648A1 Mammalian nonhuman transgenic animal having a constitutive or inducible expression of the human endonexin II gene or its muteins or its fragments |
| 01/05/2000 | EP0968228A1 Calcium phosphopeptide complexes |
| 01/05/2000 | EP0968209A1 THIAZOLE BENZENESULFONAMIDES AS $g(b) 3? AGONISTS FOR THE TREATMENT OF DIABETES AND OBESITY |
| 01/05/2000 | EP0968187A1 (-)e-2-(3,4-dichlorocinnamyl)-1-cyclopropylmethyl-piperidine and its antidiarrhoeal use |
| 01/05/2000 | EP0968133A1 Basic aluminium magnesium carbonate, method for the preparation thereof and its use as a pharmaceutical composition for treating stomach acidity |
| 01/05/2000 | EP0967985A1 Process for improving glucose metabolism, satiety, and nutrient absorption in companion animals |
| 01/05/2000 | EP0967973A2 Mediation of cytokines by melanin |
| 01/05/2000 | EP0711299B1 AZABICYCLOALKYL DERIVATIVES OF IMIDAZO(1,5-a)INDOL-3-ONE AS 5HT 3 ANTAGONISTS |
| 01/05/2000 | EP0666856B1 4-arylmethyloxymethyl piperidines as tachykinin antagonists |
| 01/05/2000 | CN1240424A Beta-sulfonamido hydroxamic acids as matrix metalloproteinase and tace inhibitors |
| 01/05/2000 | CN1240140A Traditional Chinese medicine for treating gastric disease and preparation process thereof |
| 01/04/2000 | US6011051 Use of isoxazole and crotonamide derivatives for the modulation of apoptosis |
| 01/04/2000 | US6011050 Substituted phenethylsulfones and method of reducing TNFα levels |
| 01/04/2000 | US6011044 Antiulcer agents |
| 01/04/2000 | US6010848 Screening methods using an atpase protein from hepatitis C virus |
| 01/04/2000 | CA2194103C Polypeptides useful as calcium channel blockers |
| 12/29/1999 | WO1999067363A1 Ependymal neural stem cells and method for their isolation |
| 12/29/1999 | WO1999067230A1 INHIBITORS OF α4β1 MEDIATED CELL ADHESION |
| 12/29/1999 | WO1999066948A2 Use of a dipeptide for stimulating repair processes |
| 12/29/1999 | WO1999066940A1 Use of saponins for the treatment of mucosae |
| 12/29/1999 | WO1999066925A1 Protease inhibitors |
| 12/29/1999 | WO1999066918A1 Therapeutic methods employing disulfide derivatives of dithiocarbamates and compositions useful therefor |
| 12/29/1999 | WO1999057320B1 Antisense modulation of cd40 expression |
| 12/29/1999 | WO1999054326A8 Dihydropyrimidines |
| 12/29/1999 | EP0967279A1 Helicobacter pylori cytotoxin useful for vaccines and diagnostics |
| 12/29/1999 | EP0966975A2 Diagnostic agents for pancreatic exocrine function |
| 12/29/1999 | EP0966470A1 Dioxino derivatives and their use as therapeutic agents |
| 12/29/1999 | EP0966466A1 PYRROLO 3,2-c]QUINOLINE DERIVATIVES CONTAINING HALOALKOXY GROUP AND PHARMACEUTICALLY ACCEPTABLE SALTS THEREOF |
| 12/29/1999 | EP0966447A1 Small molecules useful in the treatment of inflammatory disease |
| 12/29/1999 | EP0966443A1 Heteroaryl-hexanoic acid amide derivatives, their preparation and their use as selective inhibitors of mip-1-alpha binding to its ccr1 receptor |
| 12/29/1999 | EP0966436A1 Aryl sulfonamides and analogues thereof and their use in the treatment of neurodegenerative diseases |
| 12/29/1999 | EP0966424A1 Aminobenzophenones as inhibitors of interleukin and tnf |
| 12/29/1999 | EP0966303A2 Polypeptide conjugates for transporting substances across cell membranes |
| 12/29/1999 | EP0966297A1 Methods for regulating gastrointestinal motility |
| 12/29/1999 | EP0966295A1 Calcareous material |
| 12/29/1999 | EP0966256A1 Agents for promoting oral hygiene and oral health |